Survivors and families who lost loved ones share their akathisia experiences to help others be better informed. Akathisia is a suicide risk factor everyone should know. Akathisia is a serious, ...
My goal as host is to continue sharing powerful lived experiences while also reaching the next generation of healthcare consumers and providers.” — Ivan Kaiser, Host of Akathisia Stories CHICAGO, IL, ...
TipRanks on MSN
NRx Pharmaceuticals (NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market
NRx Pharmaceuticals (NASDAQ: NRXP) was featured in a recent article that discussed its approach to bring preservative-free ketamine-based therapies to market, pursuing distinct regulatory and ...
MedPage Today on MSN
FDA Broadens Caplyta Approval to Include Major Depression
The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback